You can buy or sell FOLD and other stocks, options, ETFs, and crypto commission-free!
Amicus Therapeutics, Inc. engages in the discovery, development, and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. Read More The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.
Cranbury, New Jersey
52 Week High
52 Week Low
Expected Nov 5, Pre-Market